Skip to main content
. 2019 Mar 5;17(5):4640–4646. doi: 10.3892/ol.2019.10109

Figure 2.

Figure 2.

Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of patients with prostate cancer. Differences in the (A) overall survival and (B) BCR-free survival between high and low expression levels of MBTD1 using Kaplan-Meier survival analyses. Kaplan-Meier survival analyses showing the difference in (C) overall survival and (D) BCR-free survival between high and low expression levels of MBTD1 in non-metastatic patients. MBTD1, malignant brain tumor domain containing protein 1; BCR, biochemical recurrence.